Inari Medical Management

Management criteria checks 3/4

Inari Medical's CEO is Drew Hykes, appointed in Jan 2023, has a tenure of 1.83 years. total yearly compensation is $5.08M, comprised of 13.8% salary and 86.2% bonuses, including company stock and options. directly owns 0.65% of the company’s shares, worth $19.28M. The average tenure of the management team and the board of directors is 2.3 years and 5 years respectively.

Key information

Drew Hykes

Chief executive officer

US$5.1m

Total compensation

CEO salary percentage13.8%
CEO tenure1.8yrs
CEO ownership0.7%
Management average tenure2.3yrs
Board average tenure5yrs

Recent management updates

Recent updates

Inari Medical, Inc. (NASDAQ:NARI) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable

Nov 07
Inari Medical, Inc. (NASDAQ:NARI) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable

Investors Interested In Inari Medical, Inc.'s (NASDAQ:NARI) Revenues

Sep 23
Investors Interested In Inari Medical, Inc.'s (NASDAQ:NARI) Revenues

Inari Medical: A Touch Of Uncertainty And Overvaluation

Jul 05

At US$43.23, Is It Time To Put Inari Medical, Inc. (NASDAQ:NARI) On Your Watch List?

Jun 18
At US$43.23, Is It Time To Put Inari Medical, Inc. (NASDAQ:NARI) On Your Watch List?

Market Participants Recognise Inari Medical, Inc.'s (NASDAQ:NARI) Revenues Pushing Shares 26% Higher

May 23
Market Participants Recognise Inari Medical, Inc.'s (NASDAQ:NARI) Revenues Pushing Shares 26% Higher

Is Inari Medical, Inc. (NASDAQ:NARI) Trading At A 29% Discount?

May 02
Is Inari Medical, Inc. (NASDAQ:NARI) Trading At A 29% Discount?

Inari Medical: Buy On Growing TAM

Mar 27

Why We're Not Concerned Yet About Inari Medical, Inc.'s (NASDAQ:NARI) 25% Share Price Plunge

Mar 08
Why We're Not Concerned Yet About Inari Medical, Inc.'s (NASDAQ:NARI) 25% Share Price Plunge

Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?

Dec 14
Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?

A Look At The Fair Value Of Inari Medical, Inc. (NASDAQ:NARI)

Oct 23
A Look At The Fair Value Of Inari Medical, Inc. (NASDAQ:NARI)

Inari Medical (NASDAQ:NARI) Is In A Strong Position To Grow Its Business

Sep 18
Inari Medical (NASDAQ:NARI) Is In A Strong Position To Grow Its Business

Is Inari Medical, Inc. (NASDAQ:NARI) Potentially Undervalued?

Aug 14
Is Inari Medical, Inc. (NASDAQ:NARI) Potentially Undervalued?

Inari Medical, Inc. (NASDAQ:NARI) Shares Could Be 23% Above Their Intrinsic Value Estimate

Jul 25
Inari Medical, Inc. (NASDAQ:NARI) Shares Could Be 23% Above Their Intrinsic Value Estimate

We Think Inari Medical (NASDAQ:NARI) Can Afford To Drive Business Growth

Jun 18
We Think Inari Medical (NASDAQ:NARI) Can Afford To Drive Business Growth

Inari Medical, Inc.'s (NASDAQ:NARI) Price In Tune With Revenues

Apr 17
Inari Medical, Inc.'s (NASDAQ:NARI) Price In Tune With Revenues

CEO Compensation Analysis

How has Drew Hykes's remuneration changed compared to Inari Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$79m

Jun 30 2024n/an/a

-US$57m

Mar 31 2024n/an/a

-US$24m

Dec 31 2023US$5mUS$700k

-US$2m

Sep 30 2023n/an/a

-US$3m

Jun 30 2023n/an/a

-US$16m

Mar 31 2023n/an/a

-US$28m

Dec 31 2022US$3mUS$500k

-US$29m

Sep 30 2022n/an/a

-US$22m

Jun 30 2022n/an/a

-US$15m

Mar 31 2022n/an/a

-US$758k

Dec 31 2021US$3mUS$450k

US$10m

Sep 30 2021n/an/a

US$16m

Jun 30 2021n/an/a

US$25m

Mar 31 2021n/an/a

US$17m

Dec 31 2020US$829kUS$384k

US$14m

Sep 30 2020n/an/a

US$7m

Jun 30 2020n/an/a

US$1m

Mar 31 2020n/an/a

US$4m

Dec 31 2019US$654kUS$316k

-US$1m

Compensation vs Market: Drew's total compensation ($USD5.08M) is about average for companies of similar size in the US market ($USD6.60M).

Compensation vs Earnings: Drew's compensation has increased whilst the company is unprofitable.


CEO

Drew Hykes (51 yo)

1.8yrs

Tenure

US$5,083,365

Compensation

Mr. Andrew J. Hykes, also known as Drew, served as Chief Operating Officer at Inari Medical, Inc. since October 2020 until December 2022 and serves as its President and Director since January 2023 and serv...


Leadership Team

NamePositionTenureCompensationOwnership
Andrew Hykes
CEO, President & Director1.8yrsUS$5.08m0.65%
$ 19.3m
Thomas Tu
Chief Medical Officer5.3yrsUS$2.50m0.47%
$ 14.0m
Paul Koehn
Senior Vice President of Operations1.8yrsno datano data
John Hsu
Vice President of Investor Relationsno datano datano data
Angela Ahmad
General Counsel & Secretary4yrsno datano data
Eric Khairy
Senior Vice President of Marketing4.9yrsno datano data
Tim Benner
Senior VP of Sales & Senior VP of U.S. Salesless than a yearno datano data
Tara Dunn
Senior VP & GM of LimFlow2.8yrsno datano data
Brian Strauss
Senior Vice President of Engineeringno datano datano data
Shon Chakrabarti
Chief Medical Officer of LimFlowless than a yearno datano data

2.3yrs

Average Tenure

51yo

Average Age

Experienced Management: NARI's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Andrew Hykes
CEO, President & Director1.8yrsUS$5.08m0.65%
$ 19.3m
Donald Milder
Independent Chair of the Board13.2yrsUS$266.47k5.27%
$ 156.1m
Jonathan Root
Independent Director13.2yrsUS$230.97k0.92%
$ 27.2m
Dana Mead
Independent Director3.1yrsUS$218.47k0.011%
$ 318.2k
Catherine Szyman
Independent Director5yrsUS$220.51k0.031%
$ 925.3k
William Hoffman
Director9.8yrsUS$198.43k0.93%
$ 27.4m
Cynthia Lucchese
Independent Director5yrsUS$235.93k0.059%
$ 1.7m
Robert Warner
Independent Director2.7yrsUS$220.97k0.012%
$ 351.9k
Rebecca Chambers
Independent Director3.4yrsUS$220.93k0.0095%
$ 280.9k

5.0yrs

Average Tenure

57yo

Average Age

Experienced Board: NARI's board of directors are considered experienced (5 years average tenure).